Table 2 Top 20 Diseases and Biofunctions associated with changes in IGF1 network mRNA expression patterns (diseases and functions significant to network molecules).
Categories | Diseases or Functions Annotation | p-Value | # Molecules |
|---|---|---|---|
Organismal Survival | organismal death | 3.64E-05 | 15 |
survival of organism | 3.90E-05 | 11 | |
Organismal Injury & Abnormalities | lymphocytic cancer | 1.11E-05 | 9 |
non-Hodgkin’s disease | 6.94E-05 | 8 | |
biliary tract tumor | 6.71E-05 | 4 | |
biliary tract cancer | 6.71E-05 | 3 | |
Respiratory Disease | obstructive pulmonary disease | 7.95E-06 | 5 |
atelectasis | 2.89E-05 | 3 | |
small cell lung cancer | 6.32E-05 | 3 | |
abnormal composition of pulmonary surfactant | 2.60E-06 | 2 | |
congenital pulmonary alveolar proteinosis | 3.66E-06 | 2 | |
community acquired pneumonia | 1.06E-05 | 2 | |
abnormal secretion of pulmonary surfactant | 4.90E-05 | 2 | |
primary atelectasis | 9.67E-05 | 2 | |
Cell Death & Survival | apoptosis of myeloma cell lines | 5.45E-05 | 5 |
survival of hepatic stellate cells | 2.87E-05 | 2 | |
DNA Replication. Recombination & Repair | DNA damage | 3.18E-05 | 5 |
Respiratory System Development & Function | abnormal morphology of type II pneumocytes | 1.11E-06 | 3 |
Inflammatory Response | cytotoxic reaction of breast cancer cell lines | 3.03E-05 | 2 |
Organ Development | growth of mammary duct | 6.59E-05 | 2 |